Patents by Inventor Gurudatt A. Chandorkar

Gurudatt A. Chandorkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION
    Publication number: 20220054460
    Abstract: Disclosed are methods of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection.
    Type: Application
    Filed: February 2, 2021
    Publication date: February 24, 2022
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Gopal KRISHNA, Gurudatt A. CHANDORKAR, Elham HERSHBERGER, Benjamin MILLER, Alan XIAO
  • Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
    Patent number: 10933053
    Abstract: Disclosed are methods of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: March 2, 2021
    Assignee: MERCK SHARP & DOHME CORP.
    Inventors: Gopal Krishna, Gurudatt Chandorkar, Elham Hershberger, Benjamin Miller, Alan Xiao
  • TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION
    Publication number: 20200093803
    Abstract: Disclosed are methods of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection.
    Type: Application
    Filed: July 29, 2019
    Publication date: March 26, 2020
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Gopal KRISHNA, Gurudatt CHANDORKAR, Elham HERSHBERGER, Benjamin MILLER, Alan XIAO
  • Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
    Patent number: 10376496
    Abstract: Disclosed are methods of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: August 13, 2019
    Assignee: Merck, Sharp & Dohme Corp.
    Inventors: Gopal Krishna, Gurudatt Chandorkar, Elham Hershberger, Benjamin Miller, Alan Xiao
  • METHODS FOR TREATING INTRAPULMONARY INFECTIONS
    Publication number: 20180296567
    Abstract: This disclosure relates to the treatment of intrapulmonary bacterial infections, including treatment of nosocomial pneumonia lung infections with pharmaceutical compositions containing the cephalosporin ceftolozane.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 18, 2018
    Inventors: Gurudatt A. CHANDORKAR, Jennifer A. HUNTINGTON, Tara PARSONS, Obiamiwe C. UMEH
  • Methods for treating intrapulmonary infections
    Patent number: 10028963
    Abstract: This disclosure relates to the treatment of intrapulmonary bacterial infections, including treatment of nosocomial pneumonia lung infections with pharmaceutical compositions containing the cephalosporin ceftolozane.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: July 24, 2018
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Gurudatt A. Chandorkar, Jennifer A. Huntington, Tara Parsons, Obiamiwe C. Umeh
  • METHODS FOR TREATING INTRAPULMONARY INFECTIONS
    Publication number: 20180064724
    Abstract: This disclosure relates to the treatment of intrapulmonary bacterial infections, including treatment of nosocomial pneumonia lung infections with pharmaceutical compositions containing the cephalosporin ceftolozane.
    Type: Application
    Filed: June 21, 2017
    Publication date: March 8, 2018
    Inventors: Gurudatt A. CHANDORKAR, Jennifer A. HUNTINGTON, Tara PARSONS, Obiamiwe C. UMEH
  • Methods for treating intrapulmonary infections
    Patent number: 9724353
    Abstract: This disclosure relates to the treatment of intrapulmonary bacterial infections, including treatment of nosocomial pneumonia lung infections with pharmaceutical compositions containing the cephalosporin ceftolozane.
    Type: Grant
    Filed: October 13, 2014
    Date of Patent: August 8, 2017
    Assignee: MERCK SHARP & DOHME CORP.
    Inventors: Gurudatt A. Chandorkar, Jennifer A. Huntington, Tara Parsons, Obiamiwe C. Umeh
  • Treating Infections with Ceftolozane/Tazobactam in Subjects Having Impaired Renal Function
    Publication number: 20160113910
    Abstract: Disclosed are methods of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection.
    Type: Application
    Filed: September 9, 2014
    Publication date: April 28, 2016
    Inventors: Gopal Krishna, Elham Hershberger, Gurudatt Chandorkar, Benjamin Miller, Alan Xiao
  • METHODS FOR TREATING INTRAPULMONARY INFECTIONS
    Publication number: 20150080360
    Abstract: This disclosure relates to the treatment of intrapulmonary bacterial infections, including treatment of nosocomial pneumonia lung infections with pharmaceutical compositions containing the cephalosporin ceftolozane.
    Type: Application
    Filed: November 21, 2014
    Publication date: March 19, 2015
    Applicant: Calixa Therapeutics, Inc.
    Inventors: Gurudatt A. Chandorkar, Jennifer A. Huntington, Tara Parsons, Obiamiwe C. Umeh
  • Treating Infections with Ceftolozane/Tazobactam in Subjects Having Impaired Renal Function
    Publication number: 20150072968
    Abstract: Disclosed is a method of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection.
    Type: Application
    Filed: May 23, 2014
    Publication date: March 12, 2015
    Applicant: Calixa Therapeutics, Inc.
    Inventors: Gopal Krishna, Gurudatt Chandorkar, Elham Hershberger, Benjamin Miller, Alan Xiao
  • METHODS FOR TREATING INTRAPULMONARY INFECTIONS
    Publication number: 20150045338
    Abstract: This disclosure relates to the treatment of intrapulmonary bacterial infections, including treatment of nosocomial pneumonia lung infections with pharmaceutical compositions containing the cephalosporin ceftolozane.
    Type: Application
    Filed: October 13, 2014
    Publication date: February 12, 2015
    Inventors: Gurudatt A. Chandorkar, Jennifer A. Huntington, Tara Parsons, Obiamiwe C. Umeh
  • METHODS FOR TREATING INTRAPULMONARY INFECTIONS
    Publication number: 20130065874
    Abstract: This disclosure relates to the treatment of intrapulmonary bacterial infections, including treatment of nosocomial pneumonia lung infections with pharmaceutical compositions containing the cephalosporin ceftolozane.
    Type: Application
    Filed: September 7, 2012
    Publication date: March 14, 2013
    Applicant: Cubist Pharmaceuticals, Inc.
    Inventors: Gurudatt A. Chandorkar, Jennifer A. Huntington, Tara Parsons, Obiamiwe C. Umeh
  • Combinations for HCV Treatment
    Publication number: 20120114604
    Abstract: The present invention relates to co-administering a Hepatitis C virus NS3/4A protease inhibitor and a cytochrome P450 monooxygenase inhibitor. The combination acts by interfering with the life cycle of the hepatitis C virus and is therefore useful as an antiviral therapy. As such, the combination may be used for treating or preventing Hepatitis C infections in patients. The invention also relates to compositions comprising the combination of inhibitors. The invention also relates to kits and pharmaceutical packs comprising a Hepatitis C virus NS3/4A protease inhibitor and a cytochrome P450 monooxygenase inhibitor. The invention also relates to processes for preparing these compositions, combinations, kits, and packs.
    Type: Application
    Filed: January 23, 2012
    Publication date: May 10, 2012
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Roger Tung, Gurudatt Chandorkar, Robert Perni
  • Combinations for HCV Treatment
    Publication number: 20100015090
    Abstract: The present invention relates to co-administering a Hepatitis C virus NS3/4A protease inhibitor and a cytochrome P450 monooxygenase inhibitor. The combination acts by interfering with the life cycle of the hepatitis C virus and is therefore useful as an antiviral therapy. As such, the combination may be used for treating or preventing Hepatitis C infections in patients. The invention also relates to compositions comprising the combination of inhibitors. The invention also relates to kits and pharmaceutical packs comprising a Hepatitis C virus NS3/4A protease inhibitor and a cytochrome P450 monooxygenase inhibitor. The invention also relates to processes for preparing these compositions, combinations, kits, and packs.
    Type: Application
    Filed: June 23, 2009
    Publication date: January 21, 2010
    Applicant: Vertex Pharmaceuticals, Inc.
    Inventors: Roger Tung, Gurudatt Chandorkar, Robert Perni
  • Combinations for HCV treatment
    Publication number: 20060003942
    Abstract: The present invention relates to co-administering a Hepatitis C virus NS3/4A protease inhibitor and a cytochrome P450 monooxygenase inhibitor. The combination acts by interfering with the life cycle of the hepatitis C virus and is therefore useful as an antiviral therapy. As such, the combination may be used for treating or preventing Hepatitis C infections in patients. The invention also relates to compositions comprising the combination of inhibitors. The invention also relates to kits and pharmaceutical packs comprising a Hepatitis C virus NS3/4A protease inhibitor and a cytochrome P450 monooxygenase inhibitor. The invention also relates to processes for preparing these compositions, combinations, kits, and packs.
    Type: Application
    Filed: October 27, 2004
    Publication date: January 5, 2006
    Inventors: Roger Tung, Gurudatt Chandorkar, Robert Perni